Autopsy report · NCT02663674

Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever)

“Study terminated due to lack of feasibility of study design.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 7 months before it stopped.
• 72 participants enrolled.
• Results were posted on the registry 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Sponsor type

US National Institutes of Health

Conditions

Coccidioidomycosis

Interventions

Fluconazole; Placebo

Participants

72

Sites

9

Countries

United States

Trials that died the same way

• Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)
  “Study was terminated due to lack of accrual.” (81% match in meaning)
• Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
  “Study was terminated due to lack of funding.” (81% match in meaning)
• Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM
  “The study was terminated due to lack of efficacy.” (81% match in meaning)
• A Study of LY3405105 in Participants With Advanced Cancer
  “The study was terminated for lack of sufficient efficacy.” (80% match in meaning)
• 3D X-ray Motion Analysis of Ankle-foot Motion After Total Ankle Arthroplasty
  “Study was terminated due to lack of funding and unforeseen delays.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.